磷霉素在人体中的药代动力学。I. 静脉给药 - Suppr

Suppr

超能文献

Pharmacokinetics of phosphonomycin in Man. I. Intravenous administration.

作者信息

Kwan K C, Wadke D A, Foltz E L

出版信息

J Pharm Sci. 1971 May;60(5):678-85. doi: 10.1002/jps.2600600504.

DOI:10.1002/jps.2600600504

PMID:5125763

Abstract

摘要

相似文献

Pharmacokinetics of phosphonomycin in Man. I. Intravenous administration.

J Pharm Sci. 1971 May;60(5):678-85. doi: 10.1002/jps.2600600504.

Characterization of phosphonomycin by microchromatographic and related techniques.

J Chromatogr. 1970 Oct 7;52(1):111-7. doi: 10.1016/s0021-9673(01)96550-1.

Pharmacodynamics of phosphonomycin after intravenous administration in man.

Antimicrob Agents Chemother (Bethesda). 1969;9:316-21.

Pharmacodynamics of phosphonomycin after oral administration in man.

Antimicrob Agents Chemother (Bethesda). 1969;9:322-6.

Clinical pharmacology and in vitro activity of phosphonomycin.

Antimicrob Agents Chemother (Bethesda). 1969;9:332-7.

Comparative pharmacokinetics of tobramycin and gentamicin.

Clin Pharmacol Ther. 1973 May-Jun;14(3):396-403. doi: 10.1002/cpt1973143396.

The influence of oximes on the distribution of 32P in the body of the rat after injection of 32P-sarin.

Biochem Pharmacol. 1970 Mar;19(3):865-76. doi: 10.1016/0006-2952(70)90249-2.

Pharmacokinetic profile of coumermycin A.

J Pharm Sci. 1970 Mar;59(3):309-13. doi: 10.1002/jps.2600590306.

The oral absorption of doxycycline by man.

Int Z Klin Pharmakol Ther Toxikol. 1969 Jan;2(1):52-5.

[Tobramycin: pharmacology in man].

Nouv Presse Med. 1974 Apr 27;3(0):59-64.

引用本文的文献

Population pharmacokinetics of intravenous fosfomycin: dose optimization for critically ill patients with and without kidney replacement therapy.

Antimicrob Agents Chemother. 2025 Jun 4;69(6):e0177924. doi: 10.1128/aac.01779-24. Epub 2025 May 5.

Development and application of neonatal physiology-based pharmacokinetic models of amikacin and fosfomycin to assess pharmacodynamic target attainment.

CPT Pharmacometrics Syst Pharmacol. 2024 Mar;13(3):464-475. doi: 10.1002/psp4.13097. Epub 2024 Jan 3.

Population plasma and urine pharmacokinetics and the probability of target attainment of fosfomycin in healthy male volunteers.

Eur J Clin Pharmacol. 2023 Jun;79(6):775-787. doi: 10.1007/s00228-023-03477-5. Epub 2023 Apr 15.

Fosfomycin: the characteristics, activity, and use in critical care.

Ther Clin Risk Manag. 2019 Mar 27;15:525-530. doi: 10.2147/TCRM.S199119. eCollection 2019.

Fosfomycin as a potential therapy for the treatment of systemic infections: a population pharmacokinetic model to simulate multiple dosing regimens.

Pharmacol Res Perspect. 2018 Feb;6(1). doi: 10.1002/prp2.378.

Fosfomycin: Pharmacological, Clinical and Future Perspectives.

Antibiotics (Basel). 2017 Oct 31;6(4):24. doi: 10.3390/antibiotics6040024.

Pharmacokinetics of intraperitoneal and intravenous fosfomycin in automated peritoneal dialysis patients without peritonitis.

Antimicrob Agents Chemother. 2012 Jul;56(7):3992-5. doi: 10.1128/AAC.00126-12. Epub 2012 May 7.

Fosfomycin: an old, new friend?

Eur J Clin Microbiol Infect Dis. 2010 Feb;29(2):127-42. doi: 10.1007/s10096-009-0833-2. Epub 2009 Nov 14.

Cefoxitin and cephalothin: antimicrobial activity, human pharmacokinetics, and toxicology.

Antimicrob Agents Chemother. 1974 Sep;6(3):290-9. doi: 10.1128/AAC.6.3.290.

Fosfomycin kinetics after intravenous and oral administration to human volunteers.

Antimicrob Agents Chemother. 1981 Sep;20(3):393-7. doi: 10.1128/AAC.20.3.393.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验